Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 5 studies | 24% ± 4% | |
myeloid cell | 4 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of LACC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 719.23 | 1443 / 1445 | 98% | 9.64 | 180 / 183 |
breast | 100% | 607.70 | 459 / 459 | 98% | 8.59 | 1093 / 1118 |
thymus | 100% | 487.76 | 652 / 653 | 97% | 6.96 | 587 / 605 |
intestine | 100% | 808.28 | 966 / 966 | 96% | 10.03 | 505 / 527 |
bladder | 100% | 742.29 | 21 / 21 | 96% | 8.04 | 482 / 504 |
stomach | 100% | 530.39 | 358 / 359 | 96% | 9.86 | 274 / 286 |
lung | 99% | 657.12 | 571 / 578 | 97% | 6.80 | 1116 / 1155 |
pancreas | 96% | 360.81 | 314 / 328 | 99% | 8.68 | 176 / 178 |
kidney | 100% | 542.78 | 89 / 89 | 94% | 9.06 | 849 / 901 |
uterus | 100% | 551.64 | 170 / 170 | 93% | 7.52 | 425 / 459 |
prostate | 100% | 583.73 | 244 / 245 | 92% | 5.18 | 462 / 502 |
skin | 100% | 716.97 | 1807 / 1809 | 90% | 6.48 | 424 / 472 |
adrenal gland | 99% | 946.53 | 255 / 258 | 88% | 8.03 | 202 / 230 |
ovary | 99% | 539.07 | 179 / 180 | 72% | 2.89 | 309 / 430 |
liver | 97% | 352.00 | 219 / 226 | 73% | 3.55 | 298 / 406 |
brain | 96% | 1136.37 | 2538 / 2642 | 72% | 4.27 | 510 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.92 | 29 / 29 |
spleen | 100% | 750.01 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 722.54 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 648.06 | 1330 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.41 | 44 / 45 |
heart | 93% | 499.23 | 797 / 861 | 0% | 0 | 0 / 0 |
muscle | 57% | 147.42 | 461 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 1.76 | 34 / 80 |
peripheral blood | 33% | 149.84 | 309 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0070431 | Biological process | nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_1900542 | Biological process | regulation of purine nucleotide metabolic process |
GO_0030641 | Biological process | regulation of cellular pH |
GO_0005634 | Cellular component | nucleus |
GO_0005777 | Cellular component | peroxisome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016682 | Molecular function | oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor |
GO_0017061 | Molecular function | S-methyl-5-thioadenosine phosphorylase activity |
GO_0047975 | Molecular function | guanosine phosphorylase activity |
GO_0004731 | Molecular function | purine-nucleoside phosphorylase activity |
GO_0046936 | Molecular function | 2'-deoxyadenosine deaminase activity |
GO_0005507 | Molecular function | copper ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004000 | Molecular function | adenosine deaminase activity |
Gene name | LACC1 |
Protein name | Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28) Laccase domain containing 1 |
Synonyms | C13orf31 FAMIN |
Description | FUNCTION: Purine nucleoside enzyme that catalyzes the phosphorolysis of adenosine, guanosine and inosine nucleosides, yielding D-ribose 1-phosphate and the respective free bases, adenine, guanine and hypoxanthine . Also catalyzes the phosphorolysis of S-methyl-5'-thioadenosine into adenine and S-methyl-5-thio-alpha-D-ribose 1-phosphate . Also has adenosine deaminase activity . Acts as a regulator of innate immunity in macrophages by modulating the purine nucleotide metabolism, thereby regulating the metabolic function and bioenergetic state of macrophages . Enables a purine nucleotide cycle between adenosine and inosine monophosphate and adenylosuccinate that prevents cytoplasmic acidification and balances the cytoplasmic-mitochondrial redox interface . The purine nucleotide cycle consumes aspartate and releases fumarate in a manner involving fatty acid oxidation and ATP-citrate lyase activity . Participates in pattern recognition receptor (PRR)-induced cytokines in macrophages: associates with the NOD2-signaling complex and promotes optimal NOD2-induced signaling, cytokine secretion and bacterial clearance . Localizes to the endoplasmic reticulum upon PRR stimulation of macrophages and associates with endoplasmic reticulum-stress sensors, promoting the endoplasmic reticulum unfolded protein response (UPR) . Does not show laccase activity . . |
Accessions | Q8IV20 A2A3Z5 ENST00000441843.5 ENST00000425906.1 ENST00000325686.7 |